Latest News about GANX
Recent news which mentions GANX
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
From Benzinga
Chardan Capital Maintains Buy Rating for Gain Therapeutics: Here's What You Need To Know
May 15, 2023
Tickers
GANX
From Benzinga
Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%
November 25, 2022
From Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
From Benzinga
From Benzinga
Gain Therapeutics Touts Additional Encouraging Preclinical Data For Lead Parkinson's Program
September 26, 2022
Tickers
GANX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
From Benzinga
Apple To $185? Here Are 5 Other Price Target Changes For Friday
August 19, 2022
From Benzinga
From Benzinga
From InvestorPlace
92 Biggest Movers From Friday
May 09, 2022
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
From Benzinga
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 15, 2022
From Benzinga
52 Biggest Movers From Yesterday
February 02, 2022
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
February 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
From Benzinga
52 Weeks High And Low Article
January 11, 2022
From Benzinga
Gain Therapeutics Stock Surges On Positive Preclinical Readout For Neurodegenerative Disease Drugs
November 10, 2021
Tickers
GANX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.